Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2019-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于2019年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the year 2019. It includes descriptions of the related parties, transaction types, estimated transaction amounts, pricing principles, and independent directors' opinions. The document is not a financial report, earnings release, or management discussion but rather a regulatory announcement about anticipated related party dealings. It does not contain financial statements or earnings data but focuses on disclosure of related party transactions as required by stock exchange rules. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2019-04-26 Chinese
2018年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制审计报告" which translates to "Internal Control Audit Report" for the fiscal year ending December 31, 2018. It contains detailed audit opinions on the effectiveness of the company's internal control over financial reporting, references to auditing standards, and evaluation of internal control deficiencies. The document is about the audit of internal controls rather than the full annual report or financial statements. It is a standalone audit report focusing on internal control effectiveness, consistent with the definition of an Audit Report / Information (AR). The document length is 7508 characters, which is sufficient to contain substantive audit content rather than a mere announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information).
2019-04-26 Chinese
独立董事关于第七届董事局第三十二次会议相关事项的专项说明和独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's special statement and independent opinions regarding various company matters for the year 2018 and plans for 2019. It includes opinions on external guarantees, profit distribution proposals, internal control self-evaluation reports, reappointment of audit firms, and expected related party transactions. The document references compliance with regulatory notices and company bylaws, and it is dated April 25, 2019. The content is focused on governance and internal control matters rather than presenting full financial statements or comprehensive annual results. The document length is 1726 characters, which is relatively short and more consistent with a governance or board-related announcement rather than a full annual report or audit report. It does not contain detailed financial data or audit results but provides independent directors' opinions on specific governance and control issues. Therefore, the most appropriate classification is Board/Management Information (MANG), as it relates to board-level opinions and governance matters.
2019-04-26 Chinese
2018年度董事局工作报告
Management Reports Classification · 95% confidence The document is titled as the "2018年度董事局工作报告" (2018 Annual Board of Directors Work Report) of Shenzhen Haier Bioengineering Co., Ltd. It contains detailed information about the company's business operations, financial performance, governance, strategic outlook, and risk management for the year 2018. The content includes comprehensive management discussion and analysis of various business segments, governance activities, and future plans. It is a detailed management report rather than a full annual report with financial statements or an earnings release. The document focuses on management's explanation of results, business trends, and outlook, which aligns with the definition of a Management Reports (MDA) filing. The length (7782 characters) and depth of content support this classification rather than a brief announcement or a full annual report (10-K).
2019-04-26 Chinese
第七届董事局第三十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 32nd meeting of the 7th Board of Directors of Shenzhen Haier Bioengineering Co., Ltd. It includes voting results on various reports and proposals such as the 2018 President's Work Report, 2018 Board Work Report, 2018 Financial Statements, Profit Distribution Plan, 2018 Annual Report, 2019 Q1 Report, internal control reports, remuneration, audit firm reappointment, related party transactions, credit applications, and the scheduling of the 2018 Annual General Meeting. The document repeatedly states that the detailed reports are published elsewhere (e.g., on the official information disclosure platform and newspapers) and that these resolutions will be submitted to the shareholders' meeting for approval. The document is about board meeting decisions and announcements of reports and proposals, not the reports themselves. The length is 4221 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, this document fits best as a Board/Management Information filing (MANG), which covers announcements of board decisions and management matters.
2019-04-26 Chinese
关于召开2018年年度股东大会通知的公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2018 Annual General Meeting (AGM) of Shenzhen Haier Bioengineering Co., Ltd. It includes information about the meeting date, voting procedures, agenda items including the 2018 annual report, financial statements, profit distribution plan, and other proposals to be voted on. The document also contains instructions for shareholders on how to register and vote, including online voting procedures and proxy authorization forms. The document is not the annual report itself but a notice and invitation to the AGM where the annual report and other matters will be discussed and voted upon. The document length is 4422 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2019-04-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.